US Patent Issued to Alexion Pharmaceuticals on Nov. 4 for "Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients" (Connecticut, Pennsylvania, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,012, issued on Nov. 4, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS) in pediatric patients" was invented by Lori Payton (Madison, Conn.), Andrew Denker (Ardmore, Pa.), Eugene Scott Swenson (Madison, Conn.), Rajendra Pradhan (New Haven, Conn.), Stephan Ortiz (Guilford, Conn.), Marc Vallee (Lexington, Mass.), Christian Mix (Wellesley, Mass.) and Xiang Gao (Guilford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for clinical treatment of Atypical Hemolytic Uremic Syndrome (aHUS) using an anti-C5 antibody, or an...